Skip to content
Clinical Trials – home
The NetherlandsBack to the Netherlands

Clinical trials in Meppel

4 clinical trials in Meppel, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.

The NetherlandsOur site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
Meppel at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Meppel

Open in trial search
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:University Of Edinburgh
Countries:The NetherlandsThe Netherlands
  • Participants:65+ years
  • Substances:Lorazepam
  • Sponsor:Amsterdam UMC

Dyslipidaemia

Not recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Meppel

What the registry says about research in the country

01 Cerebrovascular Research

Innovative research examining preventive strategies for survivors of intracerebral haemorrhage, focusing on the effectiveness of oral antiplatelet therapy in reducing major adverse cardiovascular events.

  • Stroke Prevention
  • Cardiovascular Events
  • Antiplatelet Therapy

This research aims to enhance post-stroke care protocols and improve long-term patient outcomes.

02 Neurological Disorders

Groundbreaking study investigating treatment approaches for agitated behaviour in patients with dementia, exploring personalized interventions beyond standard guidelines.

  • Behavioral Management
  • Dementia Care
  • Psychotropic Treatment

This research employs an innovative N-of-1 approach to develop targeted therapeutic solutions.

03 Cardiovascular Medicine

Advanced clinical investigation evaluating inclisiran for preventing cardiovascular events in patients with established atherosclerotic cardiovascular disease.

  • Cardiovascular Prevention
  • Heart Attack Prevention
  • Stroke Prevention

The study focuses on reducing major adverse cardiovascular events in high-risk populations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.